MRP-L2 Inhibitors
Items 1 to 10 of 13 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tigecycline | 220620-09-7 | sc-394197 sc-394197A | 5 mg 25 mg | $186.00 $439.00 | 1 | |
Although primarily an antibiotic, tigecycline has been shown to inhibit MRPL2, leading to impaired mitochondrial protein synthesis. It has been studied for its potential anticancer effects due to its ability to affect mitochondrial function. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $56.00 $240.00 $815.00 $1305.00 | 4 | |
Another antibiotic, erythromycin, has been found to inhibit MRPL2 and disrupt mitochondrial protein synthesis. It has been explored for its potential in cancer and other diseases associated with mitochondrial dysfunction. | ||||||
Doxycycline-d6 | 564-25-0 unlabeled | sc-218274 | 1 mg | $16500.00 | ||
Doxycycline, a commonly used antibiotic, has been shown to inhibit MRPL2, leading to the disruption of mitochondrial protein synthesis. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic acid, an antiepileptic drug, has been shown to inhibit MRPL2 and disrupt mitochondrial protein synthesis. Its potential effects on mitochondrial dysfunction-related conditions have been explored, including neurodegenerative diseases and cancer. | ||||||
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $53.00 | 10 | |
Chloramphenicol, an antibiotic, has been reported to inhibit MRPL2, leading to impaired mitochondrial protein synthesis. Its potential therapeutic applications have been studied, particularly in cancer research. | ||||||
Gentamicin sulfate | 1405-41-0 | sc-203334 sc-203334A sc-203334F sc-203334B sc-203334C sc-203334D sc-203334E | 1 g 5 g 50 g 100 g 1 kg 2.5 kg 7.5 kg | $55.00 $175.00 $499.00 $720.00 $1800.00 $2600.00 $6125.00 | 3 | |
Gentamicin, an antibiotic from the aminoglycoside class, has been found to inhibit MRPLIts effects on mitochondrial function and potential therapeutic uses have been investigated, particularly in the context of mitochondrial diseases. | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $51.00 $101.00 $255.00 $357.00 $714.00 | 17 | |
Macrolide antibiotics have been reported to inhibit MRPL2 and interfere with mitochondrial protein synthesis. Their potential effects on mitochondrial dysfunction-related conditions have been studied. | ||||||
Clarithromycin | 81103-11-9 | sc-205634 sc-205634A | 100 mg 250 mg | $75.00 $120.00 | 1 | |
Macrolide antibiotics have been reported to inhibit MRPL2 and interfere with mitochondrial protein synthesis. Their potential effects on mitochondrial dysfunction-related conditions have been studied. | ||||||
Pentamidine | 100-33-4 | sc-208158 sc-208158A | 25 mg 50 mg | $373.00 $557.00 | ||
Pentamidine, an antiparasitic agent in research, has been shown to inhibit MRPL2, resulting in impaired mitochondrial protein synthesis. Its potential effects on mitochondrial dysfunction-related diseases have been explored. | ||||||
Roxithromycin | 80214-83-1 | sc-205845 sc-205845A | 1 g 5 g | $51.00 $153.00 | ||
Macrolide antibiotics have been reported to inhibit MRPL2 and interfere with mitochondrial protein synthesis. Their potential effects on mitochondrial dysfunction-related conditions have been studied. | ||||||